HeartWise Analytics

Registration ID: IJNRD_303062

Published ID: IJNRD2501069

: Click Here to Get

About Hard Copy and Transparent Peer Review Report

Amruta kulthe, Mrunmayee boraste, Sachin jagdale

HeartWise Analytics, heart health prediction, machine learning, cardiovascular diseases, AI diagnostics, clinical parameters, early detection, scalable healthcare, user-friendly interface, coronary artery disease, hypertension, heart failure, arrhythmias, wearables integration, data preprocessing, Random Forest Classifier, hyperparameter optimization, feature importance, model evaluation, predictive diagnostics, personalized healthcare, real-time monitoring, global cardiovascular burden, data privacy, ethical considerations, bias in AI, healthcare cost reduction, preventative care, continuous monitoring, wearable technology.

Research Paper: HeartWise Analytics -Assessing Heart Health through Data-Driven Insights Prof Sachin Jagdale, Mrunmayee Boraste and Amruta Kulthe, Dept. of School of computing, MIT-ADT Pune, Maharashtra, India. Abstract HeartWise Analytics is a platform that uses machine learning to predict an individual’s heart health. The system processes 13 clinical parameters, many of which are well-established in medical literature as indicators of heart disease. These parameters are fed into an AI system, which classifies a person’s heart health as either “healthy” or “unhealthy.” This early identification allows healthcare providers to initiate preventive measures before the disease progresses. Key Objectives • Reliable and Scalable Assessment System: HeartWise Analytics offers a robust system capable of analyzing data from various patient sources. It’s scalable because it can be used in both high-resource hospitals and low-resource clinics, providing the same level of diagnostic accuracy. • User-Friendly Interface: The design of the system ensures that clinicians, regardless of their technical background, can easily interact with it to get actionable insights on heart health. Key Impacts 1. Early Detection: By identifying individuals at risk of cardiovascular diseases (CVD) early, healthcare providers can intervene before the disease becomes severe, potentially reducing mortality and morbidity rates. 2. Simplification of Diagnostic Workflow: Traditionally, heart disease diagnostics can be complex, requiring multiple tests and physician consultations. This system simplifies that by providing a clear, actionable result from a single dataset. Future Scope • Expansion into Predictive Diagnostics for Specific Conditions: Initially, HeartWise Analytics will detect general heart health risks. In the future, it can be expanded to identify specific diseases such as coronary artery disease (CAD), heart failure, or arrhythmias, which will help healthcare providers target treatment more precisely. • Integration with Wearables for Continuous Monitoring: The system can integrate with wearable devices like heart rate monitors, allowing for continuous heart health monitoring, helping clinicians to detect anomalies in real time. References • World Health Organization (WHO). “Cardiovascular Diseases Factsheet,” 2021. • Benjamin, E. J., et al., “Heart disease and stroke statistics—2019 update,” Circulation, 2019. A. Global Burden of Cardiovascular Diseases Cardiovascular diseases are the leading cause of death worldwide, accounting for approximately 32% of global deaths, according to the World Health Organization (WHO). The challenge of cardiovascular disease (CVD) extends beyond mortality rates—it also includes the tremendous economic cost associated with treatment and care. Statistics • Global Mortality: The WHO reported that nearly 17.9 million people die each year from CVDs. This represents a staggering portion of global deaths. • Economic Burden: The global financial impact of CVDs is projected to exceed $1 trillion annually by 2030, including treatment costs, hospitalizations, medications, and loss of productivity. Challenges in Cardiovascular Health Management 1. Late Detection and Diagnosis: Many cardiovascular diseases are diagnosed late, after irreversible damage has occurred. For example, heart attacks, often the result of undiagnosed coronary artery disease, can lead to severe outcomes. 2. Inefficient Resource Allocation in Low-Resource Settings: In low-income settings, there is often a lack of access to advanced diagnostic tools, such as echocardiograms or CT scans, making early detection difficult. 3. Rising Prevalence of Comorbidities: Conditions such as diabetes and obesity are often coexisting with CVD, compounding the risks and making treatment more complex. Major Conditions • Coronary Artery Disease (CAD): Blockage of the arteries supplying blood to the heart. CAD is the most common cause of heart attacks. • Hypertension: High blood pressure, which can cause significant damage to the heart and blood vessels over time. • Heart Failure: Occurs when the heart is no longer able to pump blood efficiently, leading to fluid buildup and fatigue. • Arrhythmias: Abnormal heart rhythms that can be life-threatening if not properly managed. References • World Heart Federation. “The Global Burden of Cardiovascular Disease.” • GBD 2019 Study, “Global Trends in Cardiovascular Diseases,” The Lancet. B. Parameters Used in HeartWise Analytics The HeartWise Analytics system evaluates 13 specific clinical parameters, each one correlated with an increased risk of heart disease. These parameters provide a comprehensive view of an individual’s cardiovascular health. Detailed Explanation of Parameters 1. Age: • Risk Factor: As individuals age, the arteries naturally lose elasticity, and plaque can accumulate, increasing the risk of heart disease. In the Framingham Heart Study, older individuals had significantly higher risks of heart failure. 2. Sex: • Risk Factor: Men typically experience heart disease at an earlier age due to hormonal differences. Women’s risks increase after menopause due to decreased estrogen levels, which offer some protective effect against CVDs. 3. Chest Pain Type (CP): • Diagnostic Value: Differentiates between typical angina (which occurs due to poor blood flow to the heart) and non-cardiac pain, such as musculoskeletal pain. Angina is a classic indicator of CVD. 4. Resting Blood Pressure (trestbps): • Risk Factor: High blood pressure is a leading cause of heart failure and stroke. A consistent measure over time can indicate whether hypertension is present, which is one of the most treatable risk factors. 5. Serum Cholesterol (chol): • Risk Factor: High cholesterol levels, especially low-density lipoprotein (LDL), lead to plaque buildup in the arteries, a primary cause of atherosclerosis. 6. Fasting Blood Sugar (fbs): • Risk Factor: Elevated blood sugar levels are a major risk factor for diabetes, which in turn increases the likelihood of heart disease due to the added strain on the circulatory system. 7. Resting Electrocardiographic Results (restecg): • Diagnostic Tool: Resting ECGs can identify arrhythmias, past heart attacks, and other abnormalities in the heart’s electrical system, providing vital information on heart health. 8. Maximum Heart Rate Achieved (thalach): • Risk Factor: A lower maximum heart rate during physical activity can indicate poor cardiovascular fitness, which is associated with higher cardiovascular risk. 9. Exercise-Induced Angina (exang): • Diagnostic Value: This parameter checks if chest pain or discomfort occurs when the heart is stressed during exercise. This symptom is often indicative of blocked arteries or ischemia. 10. ST Depression (oldpeak): • Diagnostic Tool: ST segment depression seen in an ECG during exercise indicates that the heart muscle is not getting enough oxygen, which can be a sign of coronary artery disease. 11. Slope of the ST Segment (slope): • Diagnostic Tool: Changes in the slope of the ST segment during exercise suggest how well the heart is handling physical stress and may indicate ischemia or heart failure. 12. Number of Major Vessels (ca): • Diagnostic Tool: The more blocked arteries or coronary vessels, the higher the risk of severe cardiovascular events. This parameter helps assess the extent of coronary artery disease. 13. Thalassemia (thal): • Risk Factor: Thalassemia affects the blood’s ability to carry oxygen and can lead to cardiovascular complications, including heart failure, particularly in severe cases. References • Framingham Heart Study, “Risk Factors for Cardiovascular Disease.” • American Heart Association, “Understanding Risk Factors.” C. Technical Implementation This outlines the steps taken to implement the HeartWise Analytics system using machine learning. It focuses on the dataset, preprocessing steps, choice of model, and the methods used to optimize the machine learning algorithm. 1. Data Preprocessing Preprocessing is a critical step in machine learning, as raw data often needs to be transformed into a clean and structured format before it can be used effectively. The following steps were performed: 1. Dataset (heart.csv): The dataset is sourced from publicly available heart disease datasets (such as the Cleveland Heart Disease dataset). It contains a variety of features, including demographic and clinical parameters that help in predicting heart disease. 2. Loading and Inspecting the Dataset: Initially, we load the dataset to inspect its structure, understand the type of data (numerical, categorical), and check for missing or inconsistent data. 3. Mapping Feature Names to Descriptive Names: Some features in the dataset are abbreviated (e.g., ‘trestbps’ for resting blood pressure, ‘chol’ for cholesterol), so they are mapped to more descriptive terms to improve the clarity of the model. 4. Encoding Categorical Variables: Certain features, such as sex (male or female) and thalassemia (normal or abnormal), are categorical. Machine learning algorithms typically require numerical input, so these categorical variables are encoded using a method like LabelEncoder or OneHotEncoding to convert them into numerical values. 5. Splitting Data into Training and Testing Sets: The dataset is split into 80% training and 20% testing sets. The training set is used to teach the model, while the testing set is reserved for evaluating how well the model generalizes to unseen data. 6. Standardizing Features Using StandardScaler: Many machine learning algorithms perform better when the data is scaled. For example, features like cholesterol (which could range from 100 to 500) and age (which might range from 30 to 80) need to be scaled to avoid one feature dominating others due to its larger range. StandardScaler is used to normalize the data so each feature has a mean of 0 and a standard deviation of 1. 2. Machine Learning Model Algorithm Choice: We use the Random Forest Classifier, a versatile and powerful machine learning algorithm. It is chosen for the following reasons: • High Interpretability: Random Forest models are easy to understand and interpret, allowing healthcare providers to view which features (e.g., age, cholesterol levels) have the most impact on predictions. • Feature Importance: Random Forest calculates the importance of each feature, giving healthcare providers insight into what factors contribute most to heart health. • Performance: It performs well on both classification and regression tasks and can handle missing data and categorical features naturally. Hyperparameter Optimization: • GridSearchCV is employed to find the best combination of hyperparameters for the Random Forest model. The key hyperparameters optimized include: • n_estimators (number of trees): This controls the number of trees in the forest. A higher number often leads to better performance, but also increases computation time. • max_depth: Limits the depth of each tree. A deeper tree can lead to overfitting, where the model is too tailored to the training data. • min_samples_split: Controls the minimum number of samples required to split a node. Higher values prevent the model from creating very specific (and possibly overfitted) trees. D. Model Evaluation and Results This explains how we evaluate the performance of the model and present the results of our model’s performance. 1. Metrics Used: To assess the effectiveness of our model, we use several key metrics: 1. Accuracy: Measures the overall success of the model. It is calculated as the number of correct predictions divided by the total number of predictions. However, accuracy might not always provide the full picture, especially if the classes (healthy vs unhealthy) are imbalanced. 2. Precision: Precision focuses on the false positive rate. It is defined as the number of true positives divided by the sum of true positives and false positives. This is important when the cost of false positives is high, for example, incorrectly diagnosing a healthy person as having heart disease. 3. Recall: Recall, or sensitivity, focuses on the false negative rate. It is the number of true positives divided by the sum of true positives and false negatives. High recall ensures that unhealthy individuals are caught by the model, minimizing the chances of missing those in need of intervention. 4. F1 Score: The F1 score is the harmonic mean of precision and recall. It provides a balance between the two metrics, especially in imbalanced datasets where one class might be more prevalent than the other. 2. Results: • Best Hyperparameters: After performing GridSearchCV, the optimal hyperparameters were found: • n_estimators: 100 • max_depth: 20 • min_samples_split: 5 • Performance: • Test Accuracy: 85%. This means the model correctly predicted heart health status 85% of the time on the test set. • Feature Importance: • Features such as chest pain type, ST depression, and maximum heart rate achieved were found to be the most influential in determining heart health. These parameters reflect crucial indicators of heart stress and overall cardiovascular function. E. Workflow Diagram The workflow diagram explains how data flows through the system, from input to prediction. System Workflow: 1. Data Input: Patient data is collected through medical records, wearables, or other data sources. The system accepts this data in a structured format (e.g., CSV, JSON). 2. Data Preprocessing: The input data undergoes cleaning (handling missing values), scaling (normalizing numerical features), and encoding (for categorical data) as described in Slide 5. This step ensures that the data is in the right format for the model. 3. Model Prediction: The processed data is fed into the trained Random Forest model, which outputs the predicted heart health status: healthy or unhealthy. 4. Feature Explanation: The system provides an explanation of which features most influenced the prediction (e.g., age, cholesterol level), helping healthcare providers understand the reasoning behind the diagnosis. Deployment: Once trained, the model and its components (scaler and encoder) are saved as .pkl files, which can then be deployed in a clinical setting. This allows healthcare providers to use the model for heart health assessment without needing to retrain the model each time. References: • Pedregosa, F., et al., “Scikit-learn: Machine learning in Python,” Journal of Machine Learning Research, 2011. • Breiman, L., “Random forests,” Machine Learning, 2001. Slide 8: Future Scope and Applications This slide highlights potential future directions for HeartWise Analytics to evolve, including more advanced diagnostic capabilities and integration with emerging technologies. 1. Advanced Diagnostic Tools: • The system can evolve from simple heart health classification to detecting specific diseases, such as Coronary Artery Disease (CAD), Congestive Heart Failure (CHF), or Arrhythmias. This would enable more granular diagnoses, providing targeted treatment recommendations. 2. Personalized Healthcare: • By incorporating individual risk profiles, the system could provide personalized treatment plans that include lifestyle changes, dietary adjustments, and exercise recommendations. This would allow healthcare providers to offer tailored interventions that are more effective in preventing cardiovascular diseases. 3. Real-Time Monitoring: • Integration with wearable devices (e.g., smartwatches, ECG monitors) could enable continuous monitoring of cardiovascular health, providing real-time alerts for abnormal readings. This continuous monitoring could lead to better preventative care and allow patients and healthcare providers to respond swiftly to any concerning changes. 4. Accessibility: • A major goal of HeartWise Analytics is to make cardiovascular disease diagnostics more accessible, especially in low-resource settings. By streamlining the process and requiring minimal infrastructure, the system could be deployed in regions with limited access to high-tech diagnostic equipment, providing a cost-effective solution for heart health monitoring. Let’s continue elaborating on the remaining slides. F. Global Impact This slide delves into the potential global implications of HeartWise Analytics and how it can reshape cardiovascular healthcare on a larger scale. It also acknowledges the challenges that come with implementing AI-driven healthcare solutions globally. 1. Benefits of HeartWise Analytics: The system’s potential benefits can be immense, especially in terms of improving global healthcare systems and reducing cardiovascular disease burden. 1. Reduces Healthcare Costs Through Early Detection: One of the most significant benefits of early detection is the reduction of healthcare costs. By detecting cardiovascular issues early, the need for expensive emergency interventions or long-term treatments is minimized. Early-stage heart disease, when managed appropriately, can be controlled with relatively inexpensive measures like lifestyle changes or medication, thus reducing the overall healthcare expenditure for both patients and health systems. 2. Empowers Clinicians with Scalable, Reliable Diagnostic Tools: HeartWise Analytics provides healthcare providers with a scalable, reliable, and cost-effective tool to assess heart health. It standardizes the diagnostic process, helping clinicians across different regions provide consistent care. The model can also assist in remote or under-resourced areas where experienced cardiologists might not be available, ensuring that every patient receives an accurate, data-driven heart health assessment. 3. Encourages Preventative Care Among At-Risk Populations: HeartWise Analytics encourages preventative care, which is crucial in managing the rising prevalence of heart diseases. By identifying individuals at risk of cardiovascular diseases, the system helps healthcare providers to intervene before conditions become severe. This could lead to the promotion of heart-healthy lifestyles (e.g., better diet, regular physical activity), ultimately leading to a healthier population and fewer people requiring complex heart treatments later in life. 2. Challenges: Although the system provides substantial benefits, it is not without challenges, particularly regarding data privacy, ethical considerations, and the need for fairness in the models. 1. Data Privacy and Ethical Considerations in AI-Driven Healthcare: AI in healthcare involves collecting and analyzing sensitive patient data. Data privacy and security are of paramount importance to ensure that patient information is protected. There are also ethical considerations, such as: • Informed Consent: Patients must be fully aware of how their data will be used and provide consent for analysis. • Data Ownership: Questions regarding who owns patient data (the individual, the healthcare provider, or the company) need to be clearly addressed. • Bias and Fairness: The model must be designed to avoid biased predictions. AI models are only as good as the data they are trained on, and if the dataset contains biased or incomplete information, the model might give inaccurate or unfair results for certain populations. 2. Ensuring Model Fairness Across Diverse Populations: Cardiovascular diseases affect different populations in varying ways. For instance, individuals from certain ethnic backgrounds might experience heart disease differently or exhibit different risk factors. It is essential to ensure that the model can generalize across various demographic groups. Continuous monitoring and evaluation are required to ensure that the AI system doesn’t inadvertently discriminate against specific groups, especially when deployed at a global scale. G. Conclusion This summarizes the potential impact of HeartWise Analytics and outlines the next steps in its development and deployment. HeartWise Analytics: A Scalable, Accurate System to Evaluate Heart Health HeartWise Analytics offers a scalable, user-friendly, and accurate system that uses AI to predict heart health, making it suitable for widespread use in a variety of healthcare settings. With its potential to revolutionize cardiovascular diagnostics, the system is poised to play a key role in reducing the global burden of cardiovascular diseases. Key Benefits: • Early Intervention: HeartWise Analytics can help healthcare providers identify patients at risk of heart disease before it becomes critical, allowing for early intervention. By identifying individuals with early-stage risk factors, healthcare systems can focus on preventative measures and reduce the need for emergency care. • Promoting Personalized Treatment: With its ability to integrate individual data, the system can provide tailored treatment recommendations based on a person’s unique risk factors, ensuring that interventions are highly targeted and effective. • Reducing the Global Burden of Heart Diseases: By offering accessible and accurate heart health assessments, the system could potentially reduce the global burden of heart disease—currently the leading cause of death worldwide. Early detection and consistent monitoring could mitigate the rising incidence of heart disease and significantly improve public health outcomes globally. Next Steps: The current version of HeartWise Analytics is just the beginning. Several future developments are planned: 1. Expansion into Predictive Diagnostics: The system will evolve to not only predict the likelihood of heart disease but also identify specific heart conditions, such as Coronary Artery Disease (CAD) or Congestive Heart Failure (CHF). 2. Collaboration with Wearable Technology Providers: Partnering with wearable technology companies could allow for continuous monitoring of heart health metrics, providing a real-time feed of data that the system can analyze to offer up-to-the-minute diagnostics and intervention recommendations.  References 1. Benjamin, E. J., et al. (2019). “Heart disease and stroke statistics—2019 update.” Circulation. This reference provides an overview of global cardiovascular disease statistics, including prevalence, mortality, and risk factors. It underscores the need for more effective cardiovascular disease prevention strategies and highlights the growing global burden of heart disease. 2. Fuster, V., et al. (2020). “The future of cardiovascular health.” European Heart Journal. Fuster discusses advancements in cardiovascular health diagnostics and the future role of technology in managing heart disease, which aligns with the goals of HeartWise Analytics. 3. Pedregosa, F., et al. (2011). “Scikit-learn: Machine learning in Python.” Journal of Machine Learning Research. This paper discusses the Scikit-learn library, a cornerstone of the Python ecosystem for machine learning, which was used for developing the machine learning model in this research. 4. Breiman, L. (2001). “Random forests.” Machine Learning. Breiman’s foundational paper on Random Forests explains how this algorithm works and why it was chosen for this project. Random Forests are ideal for medical applications due to their interpretability and ability to handle complex data. 5. World Health Organization. (2021). “Cardiovascular Diseases (CVDs).” The WHO’s report on cardiovascular diseases gives comprehensive data on the global impact of CVDs, further emphasizing the need for scalable diagnostic tools like HeartWise Analytics.

Published Paper   E-Certificate

Amruta kulthe, Mrunmayee boraste, & Sachin jagdale (January-2025). HeartWise Analytics . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 10(1), a619-a624. https://ijnrd.org/papers/IJNRD2501069.pdf

Volume 10 Issue 1, January-2025

Pages : a619-a624

Paper Reg. ID: IJNRD_303062

Published Paper Id: IJNRD2501069

Research Area: Science and Technology

Author Type: Indian Author

Country: NASHIK/NASHIK, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2501069.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2501069

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International UGC CARE JOURNAL PUBLICATION, Low Cost, Scholarly Open Access, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2026 - Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 11 | Issue 3 | March 2026

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the New UGC CARE Transparent Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

Transparent Peer Review Journal Publication: IJNRD operates a strict double-blind peer review system managed by 3000+ expert reviewers, ensuring ethical, unbiased, and high-quality review for every research paper.

For Indian Authors : Get a transparent peer review report from Scholar9.com for just ₹1000. View Sample Report

For Foreign Authors : A detailed peer review report is available through Scholar9.com for $20 USD. View Sample Report

Transparent Peer Review Journal Publication

⭐ Transparent Peer Review | 🕵️‍♂️ Double-Blind | 👨‍🏫 3000+ Expert Reviewers | 🇮🇳 Report for India Author ₹1000 | 🌐 Report for Foreign Author $20 | 📄 Sample Reports on Scholar9.com | 🌍 High Credibility | ⚖️ Ethical & Unbiased Evaluation

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Recently, the UGC discontinued the UGC-CARE Journal List and introduced new parameters that allow publication in Transparent Peer-Reviewed (Refereed) Journals. IJNRD is Transparent Peer Review Journal Valid As per New UGC Notification.

You can now publish your research paper in IJNRD.ORG. IJNRD is a Transparent Peer-Reviewed Open Access (Refereed Journal), UGC and UGC CARE Approved, Crossref DOI, Multidisciplinary, Impact Factor calculate by Google Scholar. As an International, open-access, and online journal, Publishing with us ensures wider reach, academic credibility, and enhanced recognition for your work.

For more details, refer to the official notice: UGC Public Notice

⭐ Low Cost ₹1570 | 📚 UGC CARE Approved | 🔍 Peer-Reviewed | 🌐 Open Access | 🔗 Crossref DOI & Global Indexing | 📊 Google Scholar Impact Factor | 🧪 Multidisciplinary

Submit Paper Online  Call for Paper  About IJNRD UGC CARE Approval

Important Dates for Current issue

Paper Submission Open For: March 2026

Current Issue: Volume 11 | Issue 3 | March 2026

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Mar-2026

Notification of Review Result: Transparent peer review process - your paper is evaluated by experts, and you receive acceptance or rejection updates via email and SMS.

Publication of Paper: Once all documents are submitted, your paper is published without delay, and you can instantly download your certificate and confirmation letter online.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an international open-access journal offering Low Cost Journal Publication, transparent Peer Review Journal Publication, Crossref DOI, and multidisciplinary research visibility under UGC CARE Approved Journal Publication.

Subject Category: Research Area

Approval, Licenses and Indexing: More Details

Call For Paper - Volume 11 | Issue 3 | March 2026

IJNRD.org offers low-cost journal publication starting at ₹1570 with UGC CARE Approved, refereed, peer-reviewed, open-access publishing. This multidisciplinary monthly journal, available in both online and print formats, features a strong Google Scholar-based impact factor of 8.76, Transparent Peer Review, CrossRef DOI, global indexing, fast publication, and complete metadata for maximum research visibility and citation impact across multidisciplinary domains.

Volume 11 | Issue 3 | March 2026 | IJNRD Transparent Peer Review Certificate | Submit Paper Online till 31-Mar-2026

⭐ UGC CARE Approved Refereed Journal | 🔍 Transparent Peer Review | 🌐 Open Access Publishing | 💰 Low-Cost ₹1570 | 🔗 CrossRef DOI & Global Indexing | 📊 Google Scholar Impact Factor 8.76 | 🧪 Multidisciplinary | Online & Print

Submit Paper Online